Quantifying people living with HIV who would benefit from an alternative to daily oral therapy: Perspectives from HIV physicians and people living with HIV

Quantifying people living with HIV who would benefit from an alternative to daily oral therapy: Perspectives from HIV physicians and people living with HIV

Introduction Current antiretroviral therapies (ARTs) require daily oral dosing, which is a challenge for some people living with HIV (PLHIV). Measures of treatment needs that are associated with daily oral ARTs have been identified in studies/interviews with healthcare professionals (HCPs) and PLHIV...

Full description

Bibliographic Details
Main Authors: Laura Clark, Chitra Karki, Josh Noone, Jenny Scherzer, Martina Bode, Paolo Rizzini, Fabio Vecchio, Laetitia Roustand, Gaelle Nachbaur, Laurent Finkielsztejn, Vasiliki Chounta, Nicolas Van de Velde
Format: Article
Language:English
Published: European Publishing 2020-10-01
Series:Population Medicine
Subjects:
hiv
adherence
injectable antiretroviral therapy
long-acting hiv treatment
cabotegravir cab
rilpivirine rpv
Online Access:http://www.journalssystem.com/popmed/Quantifying-people-living-with-HIV-who-would-benefit-from-an-alternative-to-daily,126632,0,2.html

Internet

http://www.journalssystem.com/popmed/Quantifying-people-living-with-HIV-who-would-benefit-from-an-alternative-to-daily,126632,0,2.html

Similar Items